Nuance Pharma Attended The 3rd BioCentury-BayHelix East-West Biopharma Summit in Singapore

Nuance Pharma Attended The 3rd BioCentury-BayHelix East-West Biopharma Summit in Singapore

Nuance Pharma attended the 3rd BioCentury-BayHelix East-West Biopharma Summit in Singapore, an energizing gathering of partners and investors in the emerging Pan-Asia bio-community. Innovations and insights exchanged on panels underscored Asia’s relevance and growth as a central player in the global biopharma landscape.

Mr. Mark Lotter, founder and CEO of Nuance Pharma, was invited to address at the scene-setting panel on how Asia's evolving Arc of Innovation and the expanding East-West ecosystem can transform drug discovery and development.

As Nuance Pharma initiates its expansion into the Asia Pac region and continues to partner with leading Biopharma players in the West, the BioCentury-BayHelix East-West Biopharma Summit proved to be a perfect platform off which to further foster the expansion process. The summit brought a broad spectrum of players across the value chain, representing the best from the East and West, which in turn allows for a more informed and detailed interaction between the players.

Nuance Pharma looks forward to building on the workstreams initiated during the week as part of the ambition to expand the company.